Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ammitzbøll

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Neuroimmunology|October 27, 2019
Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosisE R Petersen, C Ammitzbøll, H B Søndergaard, et al.
Multiple Sclerosis and Related Disorders|January 12, 2018
Disability in progressive MS is associated with T2 lesion changesC Ammitzbøll, T B Dyrby, M Lyksborg, et al.
Multiple Sclerosis and Related Disorders|July 7, 2023
NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosisC Ammitzbøll, T B Dyrby, L Börnsen, et al.
Scandinavian Journal of Rheumatology|July 10, 2018
Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trialC H Brahe, M Østergaard, J S Johansen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Neuroimmunology|October 27, 2019
Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosisE R Petersen, C Ammitzbøll, H B Søndergaard, et al.
Multiple Sclerosis and Related Disorders|January 12, 2018
Disability in progressive MS is associated with T2 lesion changesC Ammitzbøll, T B Dyrby, M Lyksborg, et al.
Multiple Sclerosis and Related Disorders|July 7, 2023
NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosisC Ammitzbøll, T B Dyrby, L Börnsen, et al.
Scandinavian Journal of Rheumatology|July 10, 2018
Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trialC H Brahe, M Østergaard, J S Johansen, et al.
Pageof 1